about
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber,...
Read More
0.64
-0.01
(-1.54%)
23,660
XNAS Volume
XNAS 20 Feb, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Cytosorbents Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..